PHARMAFOCUS AND PHARMAFILE

The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over its vaccine supplies,...

It was confirmed yesterday that the Pharmacovigilance Risk Assessment Committee (PRAC) has provided updated guidance for use of J&J’s vaccine,...

GSK will use the CGT Catapult facility to perform GMP cell processing that will accelerate its cell and gene therapy pipeline for clinical...

Preparations for the start of production, technology transfer, and test runs are already underway. Following final agreement, Novartis plans to...

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and marketing of up to one...

The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to...

Moderna has revealed a second investment of $472 million from the US Government’s Biomedical Advanced Research and Development Authority (BARDA)...

The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. The FDA has...

The FDA has granted Pfizer and BioNTech’s COVID-19 vaccine candidates Fast Track status to speed up their development and review. The FDA has...

The deal is for 100 million doses of the candidate by the end of this year, known as AZD1222, which AZ is working on in partnership with the...